BMJ
出版商：BMJ · ISSN：0959-8138, 1756-1833, 0966-6494, 1468-5833, 0267-0623, 0959-535X, 0959-8154, 1759-2151, 0007-1447, 1752-069X, 0959-8146 · 类型：journal
研究主题：Diverse Scientific and Economic Studies · Human auditory perception and evaluation · Healthcare Policy and Management · Healthcare Systems and Challenges · Medical History and Innovations
核心指标
- 影响因子(JCR 2025):55.100
- JCR 分区:Q1(MEDICINE, GENERAL & INTERNAL)
- 中科院分区(2025):医学 1区(Top);小类:MEDICINE, GENERAL & INTERNAL 医学：内科 1区
- 新锐分区(2026):医学 1区
- SJR:1.988(Q1)
- h-index:613
- i10 指数:45784
- 载文量 389469 · 总被引 3993837
逐年趋势
- 近年影响因子:2021 93.3 → 2022 106 → 2023 93.6 → 2024 42.7 → 2025 55.1
- 近年 SJR:2021 2.29(Q1) → 2022 2.87(Q1) → 2023 2.8(Q1) → 2024 2.98(Q1) → 2025 1.99(Q1)
投稿参考
- 审稿周期:首次审稿意见平均约 1.5 个月
- 投稿人评价:3.2 分(5 条评价)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- Kidney International Supplements — IF 89.6 · JCR Q1 · 中科院2区
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Signal Transduction and Targeted Therapy — IF 81.2 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
常见问题
《BMJ》的影响因子是多少?
根据 JCR 2025 年数据,《BMJ》的最新影响因子(IF)为 55.100。
《BMJ》是几区期刊?
《BMJ》中科院分区(2025年版)为医学1区(Top 期刊),JCR 分区为 Q1。
《BMJ》的审稿周期多久?
根据投稿经验数据,《BMJ》首次审稿意见平均约 1.5 个月返回,实际周期因稿件而异。
本刊近期代表论文
- Time trends in the male to female ratio for autism incidence: population based, prospectively collected, birth cohort study (2026 · 被引 19)
- Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial (2026 · 被引 16)
- Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial (2026 · 被引 5)
- Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial (2026 · 被引 4)
- Accelerated continuous theta burst stimulation targeting left primary motor cortex for children with autism spectrum disorder: multicentre randomised sham controlled trial (2026 · 被引 2)
- Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021 (2025 · 被引 498)